| Existing agents, novel agents, or transplantation for high-risk MDS |
|
Hematology. American Society of Hematology. Education Program |
Myelodysplastic Syndromes (MDS) |
| Experience of life quality from patients with aplastic anemia: a descriptive qualitative study |
|
Orphanet Journal of Rare Diseases |
Aplastic Anemia |
| Expert consensus on the management of pharmacodynamic breakthrough-hemolysis in treated paroxysmal nocturnal hemoglobinuria |
|
Hematology. |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
| Exploring treatment strategies for paroxysmal nocturnal hemoglobinuria: an overview of registered clinical trials |
|
Current Medical Research and Opinion |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
| Factor B inhibitor iptacopan for the treatment of paroxysmal nocturnal hemoglobinuria |
|
Blood Reviews |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
| Family reflections: George Elliott: a first-person commentary on pediatric aplastic anemia research |
|
Pediatric Research |
Aplastic Anemia |
| Family reflections: pediatric aplastic anemia research; a parent perspective |
|
Pediatric Research |
Aplastic Anemia, Pediatric |
| Fatigue, symptom burden, and health-related quality of life in patients with myelodysplastic syndrome, aplastic anemia, and paroxysmal nocturnal hemoglobinuria. |
|
Cancer Med |
Aplastic Anemia, Myelodysplastic Syndromes (MDS), Paroxysmal Nocturnal Hemoglobinuria (PNH) |
| Fit older adults with advanced myelodysplastic syndromes: who is most likely to benefit from transplant? |
|
Leukemia & Lymphoma |
Myelodysplastic Syndromes (MDS) |
| Flaming and fanning: The Spectrum of inflammatory influences in myelodysplastic syndromes |
|
Blood Reviews |
Myelodysplastic Syndromes (MDS) |
